Tricuspid Valve

This channel is dedicated to news and trends in tricuspid valve interventions, surgical and transcatheter, to manage regurgitation and valve stenosis. The tricuspid valve is a rapidly growing area in structural heart interventions. Minimally invasive transcatheter tricuspid valve replacement (TTVR) and repair using transcatheter edge to edge repair (TEER) clips are expected to become a new standard of care in the next couple years, partly because open heart tricuspid surgery has historically has poor outcomes.

Mitral and_tricuspid transcatheter valves Evoque and Intrepid were discussed at TVT 2022.

VIDEO: Advances in transcatheter tricuspid and mitral valve technology

Anita W. Asgar, MD, director, transcatheter valve therapy research at Montréal Heart Institute, discusses advances and new technology for mitral and tricuspid valves at the 2022 Transcatheter Valve Therapies (TVT) meeting. 

Adam Greenbaum, MD, Emory, explains the CLASP TR trial of the Pascal clip device for transcatheter repair, which was a late-breaking ACC22 study.

VIDEO: Pascal effective in transcatheter repair of tricuspid valve regurgitation

Adam Greenbaum, MD, co-director of the Structural Heart and Valve Center at Emory University Hospital Midtown in Atlanta, explains details from the late-breaking CLASP TR trial at ACC.22.

Tricuspid valve annuloplasty during mitral valve surgery offers key benefits

The new analysis focused on 98 patients who presented with primary mitral regurgitation.

Thumbnail

TTVR patients see consistent improvements in their daily lives

Researchers evaluated 115 patients before and one month after undergoing transcatheter tricuspid valve repair, sharing their findings in JACC: Cardiovascular Interventions

Thumbnail

TAVR provides comparable value for low-risk patients with bicuspid and tricuspid AS

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 

Thumbnail

Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

FDA grants breakthrough device designation to Medtronic TTVR system, approves early feasibility study

According to Medtronic, its Intrepid TTVR system helps meet a “large, unmet clinical need.”

Thumbnail

TTVR improves outcomes for patients with severe tricuspid regurgitation

Transcatheter edge-to-edge tricuspid valve repair (TTVR) is an effective treatment option for patients with severe tricuspid regurgitation (TR), according to a new study published in JACC: Heart Failure.